To the best of our knowledge, this is the first study to show that RGS19 is an oncogene that promotes the proliferation and metastasis of HCC cells by activating the β-catenin/c-Myc axis with the assistance of MYH9. This evidence concerns the gene MYC and hepatocellular carcinoma.